Hitoshi Yokoyama
- Nephrology top 0.05%
- Renal Diseases and Glomerulopathies 85
- Chronic Kidney Disease and Diabetes 45
- Transplantation top 1%
-
- Cardiac Valve Diseases and Treatments 14
- Immunology top 2%
-
- Systemic Lupus Erythematosus Research 24
-
- Vasculitis and related conditions 22
- Aortic Disease and Treatment Approaches 16
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 19
-
- Cardiac and Coronary Surgery Techniques 18
- Co-authors
- Seiichi MatsuoEnyu ImaiKunihiro YamagataMasaru HorioAkira HishidaYasuhiko TominoYoshinari YasudaKimio Tomita
- Partner nations
- JapanUnited StatesSlovakia
In The Last Decade
Hitoshi Yokoyama
252 papers receiving 11.2k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Nephrology 4.6k
- Transplantation 289
- Cardiology and Cardiovascular Medicine 2.2k
- Endocrinology, Diabetes and Metabolism 1.3k
- Immunology 1.5k
Countries citing papers authored by Hitoshi Yokoyama
This map shows the geographic impact of Hitoshi Yokoyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Yokoyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Yokoyama more than expected).
Fields of papers citing papers by Hitoshi Yokoyama
This network shows the impact of papers produced by Hitoshi Yokoyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Yokoyama. The network helps show where Hitoshi Yokoyama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hitoshi Yokoyama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 8 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 5 | |
| 7 | 2018 | 8 | |
| 8 | 2017 | 53 | |
| 9 | 2014 | 8 | |
| 10 | Inhibition of bladder hypersensitivity by interleukin 4 (IL-4) gene therapy using herpes simplex virus (HSV) vectors in rats with cyclophosphamide induced cystitis | 2013 | 1 |
| 11 | Reliability and validity of cough peak flow measurement | 2012 | 1 |
| 12 | 2012 | 1 | |
| 13 | Increased Skin TRPM8 by Estrogen Deficiency May Induce Detrusor Overactivity Mediated Alpha1D-Adrenergic Receptors Triggered by Sudden Cold Stress | 2012 | 1 |
| 14 | 2009 | 1 | |
| 15 | 2008 | 18 | |
| 16 | 2004 | 277 | |
| 17 | 2004 | 31 | |
| 18 | 2003 | 37 | |
| 19 | [Guidelines for the management of refractory nephrotic syndrome--from investigations between 1997 and 2001--research project team for progressive renal lesions in the Ministry of Health, Labor and Welfare, Japan]. | 2002 | 3 |
| 20 | Strategies for Treatment of Adult Nephrotic Syndrome by Cyclosporin A (Cyclosporine) | 1999 | 1 |
About Hitoshi Yokoyama
Hitoshi Yokoyama is a scholar working on Nephrology, Transplantation and Pulmonary and Respiratory Medicine, having authored 268 papers that have together received 11.4k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (85 papers), Chronic Kidney Disease and Diabetes (45 papers), Systemic Lupus Erythematosus Research (24 papers), Vasculitis and related conditions (22 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers), Cardiac and Coronary Surgery Techniques (18 papers), Aortic Disease and Treatment Approaches (16 papers) and Cardiac Valve Diseases and Treatments (14 papers). The work is most often cited by research in Nephrology (4.6k citations), Transplantation (289 citations) and Cardiology and Cardiovascular Medicine (2.2k citations). Hitoshi Yokoyama has collaborated with scholars based in Japan, United States and Slovakia. Frequent co-authors include Seiichi Matsuo, Enyu Imai, Kunihiro Yamagata, Masaru Horio, Akira Hishida, Yasuhiko Tomino, Yoshinari Yasuda, Kimio Tomita, Kosaku Nitta and Takashi Wada.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.